FentaNYL Citrate in 0 recalled over sterility concerns
- Recall date
- July 25, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SterRx, LLC recalls fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue…
- Recall number
- D-1332-2022
- FDA classification
- Class II
- Brand / firm
- SterRx, LLC
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-327-02.
Get recall alerts
Free email alert whenever SterRx, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SterRx, LLC